Robot Surgery Executive Sells Shares Worth 400 Million Won

Amy L. Ladd, an inside director at Intuitive Surgical Inc. (NASDAQ: ISRG), sold common stock in two market transactions on April 28 and 29 under a pre-established Rule 10b5-1 trading plan, generating approximately $292,000 (about KRW 400 million) in proceeds. After these sales, her direct holdings declined to roughly 120 shares, indicating she deliberately divested only a portion of her total stake, according to the company’s disclosure.

In its April 21 Q1 2026 earnings report, Intuitive Surgical posted double-digit year-over-year growth in both revenue and net income—driven by an increase in robotic surgery procedures—and exceeded market expectations. The stock has recently experienced heightened volatility, as investors weigh an FDA notice on surgical staplers alongside the company’s 2026 procedure-volume growth forecast.

Headquartered in California, Intuitive Surgical is the global leader in robot-assisted minimally invasive surgery, driving adoption of robotic procedures in laparoscopy, thoracic, and urologic specialties through its da Vinci Surgical System and Ion platform.